MGteam

Great question! Vyvgart Hytrulo (efgartigimod) has shown some promising results for people with generalized myasthenia gravis (gMG). In clinical trials, many people started noticing improvements within the first treatment cycle.

Here's what the research shows:

- Meaningful improvements were seen after just 4 weeks of Show Full Answer

Great question! Vyvgart Hytrulo (efgartigimod) has shown some promising results for people with generalized myasthenia gravis (gMG). In clinical trials, many people started noticing improvements within the first treatment cycle.

Here's what the research shows:

- Meaningful improvements were seen after just 4 weeks of treatment
- More than 80% of participants showed clinically meaningful improvements at the one-year mark
- Nearly 1 in 3 people reached "minimum symptom expression," meaning very few or no symptoms at all

Improvements were measured across daily living activities like:

- Speech
- Chewing and swallowing
- Breathing
- Vision
- Arm and leg strength Everyone's experience is different, and results can vary depending on which antibody type is involved. Some people may notice changes sooner, while others may take longer.

It's always worth keeping your neurology team updated on how you're feeling after each treatment cycle so they can track your progress and adjust your plan if needed.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

FDA Expands Vyvgart Approval to All Adults With gMG

80% See MG Symptom Relief in Early Cell Therapy Trial